Skip to main content

Table 4 Transfusion and substitution of coagulation factors (N = 63)

From: Runtime and aPTT predict venous thrombosis and thromboembolism in patients on extracorporeal membrane oxygenation: a retrospective analysis

 

All

NO VT/VTE

VT/VTE

p

PRBC Units (U)

21.86 ± 26.15

17.15 ± 22.54

27.38 ± 29.27

0.068

PRBC U/day

0.96 ± 1.12

0.88 ± 0.84

1.31 ± 1.88

0.629

Platelets U

5.00 ± 9.17

3.97 ± 7.68

6.21 ± 10.68

0.532

Platelets U/day

0.20 ± 0.45

0.18 ± 0.31

0.30 ± 0.68

0.862

FFP U

4.97 ± 10.36

3.12 ± 7.38

7.14 ± 12.83

0.092

FFP U/day

0.30 ± 0.87

0.24 ± 0.89

0.38 ± 0.85

0.138

AT III U**

1.61 ± 3.12

1.76 ± 3.67

1.43 ± 2.33

0.955

AT III U/day**

0.08 ± 0.17

0.09 ± 0.20

0.07 ± 0.13

0.861

Factor XIII

2.35 ± 3.38

1.71 ± 2.43

3.10 ± 4.16

0.118

Factor XIII U/day

0.12 ± 0.16

0.10 ± 0.14

0.14 ± 0.17

0.290

  1. PRBC packed red blood cells, FFP fresh frozen plasma, AT III antithrombin III, AT III unit á 500 IE; Factor XIII unit á 1250 IE. Values are displayed as mean ± SD. Differences were analyzed using Mann–Whitney U test and were considered significant if p ≤ 0.05. For multivariable test, values ≤0.1 were considered for further analyses